Lipella Pharma (LIPO): Operating Profitability

LIPO (Lipella Pharma) - company brandmark

The historical operating margin on the GURU.Markets chart for Lipella Pharmaceuticals (LIPO) demonstrates volatility, with the indicator standing at 0.00. This price action reflects the implementation of liposomal drug delivery, the scaling of urogenital inflammation therapy, and the development of the LP-10 drug for bladder cancer. These factors determine the current business efficiency within the specialty pharmaceuticals segment.

lipella.com (LIPO): Operating Profitability from 04/28/2023 to 07/19/2025

lipella.com - analytical breakdowns and key metrics (LIPO)

- share price and consensus valuation forecast:
Summary company analytics:Lipella, LIPO
Brand item of Lipella Pharmaceuticals

Operating margin measures cost management efficiency by determining the share of profit from core operations before interest and taxes relative to total revenue. By analyzing the operating profit margin before interest and taxes, an investor assesses the ability of Lipella Pharmaceuticals (LIPO) to monetize therapeutic agents for tissue regeneration and withstand costs when scaling the supply of drugs to clinics.

Competitor analysis for Lipella Pharmaceuticals

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|TNF Pharmaceuticals - Operating Profit Margin|Operating Margin YCBD|Operating Margin PainReform Ltd. (PRFX)|Operating Profitability Altamira Therapeutics Ltd CYTO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.